基本信息
views: 3
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
At AstraZeneca PLC, I was the Medical Science Director for AstraZeneca’s Boston site, responsible for the medical and clinical aspects of development of agents from chemical lead identification through clinical proof of concept in phase II. I was responsible for the design and interpretation of the entire clinical development plan for five agents. This position had global responsibilities with clinical trials in the US, Canada, European Union, Japan and Korea. I was a member of the Strategic Planning & Business Development as an ad hoc member and was the global Disease Area Clinical Expert for Hematology.
Research Interests
Papers共 291 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cancer Researchno. 7 (2024)
Nature communicationsno. 1 (2024): 4091-4091
Yiduo Hu,Azeet Narayan, Yunshan Xu, Julia Wolfe,Dennis Vu,Thi Trinh,Chaitanya Kantak,S Percy Ivy,Joseph Paul Eder,Yanhong Deng,Patricia LoRusso,Joseph W Kim,
CANCER INVESTIGATIONno. 7 (2023): 646-655
crossref(2023)
S. Sen,A. I. Spira,D. Sommerhalder, F. Meric-Bernstam, V. Subbiah,J. D. Berlin,A. Parikh, M. Cecchini,R. E. Sanborn, P. V. Chablani,G. E. Peoples,T. Schurpf,
ANNALS OF ONCOLOGY (2023): S649-S650
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
Load More
Author Statistics
#Papers: 291
#Citation: 27619
H-Index: 63
G-Index: 165
Sociability: 7
Diversity: 3
Activity: 37
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn